Clinical Trial Update: ACT-20 in Patients With Severe COVID-19 Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

An update on the ACT-20 trial in patients with severe COVID-19 pneumonia across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• ACT-20

Snippet

Sponsor: Aspire Health Science | Conditions: COVID-19 Pneumonia | Phase 1, Phase 2 | Status: UNKNOWN